NB-PP_1170x120

biopharmaceutical research

Health policy in 2017: Innovation, value and access

Health policy in 2017: Innovation, value and access

For the past two years, organizations in the private and public sectors have been working to develop tools to support value-based health care and evidence-based medical decision making. In 2017, these efforts will take on an even greater urgency, driven by the ongoing, accelerating progress of biopharmaceutical research and development. As more — and more